X
ACHEMA MIDDLE EAST 2026
Pharma Advancement
DDF Summit 2025
  • Home
  • Articles
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    idiopathic pulmonary fibrosis

    US FDA Approves Jascayd for Idiopathic Pulmonary Fibrosis

    Tissue Repair Drug

    FDA Clears Tissue Repair Drug AD-NP1 For Clinical Trials

    FastTrack Review

    US FDA Launches Fast-Track Review Scheme for Generic Drugs

    AI Based Drug Discovery

    Bristol Myers, Takeda, Astex to Back AI Based Drug Discovery

    wearable drug delivery devices

    Wearable Drug Delivery Devices for On-Demand Care

    biologic drug formulation stability

    Breakthroughs in Biologic Drug Formulation Stability

    high volume injectable formulations

    Overcoming Challenges in High-Volume Injectable Formulations

    lipid nanoparticles in RNA therapies

    Lipid Nanoparticles in RNA and Gene Therapies

    Breast Cancer Therapy

    US FDA Approves Breast Cancer Therapy Inluriyo by Eli Lilly

  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us
No Result
View All Result
  • Home
  • Articles
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    idiopathic pulmonary fibrosis

    US FDA Approves Jascayd for Idiopathic Pulmonary Fibrosis

    Tissue Repair Drug

    FDA Clears Tissue Repair Drug AD-NP1 For Clinical Trials

    FastTrack Review

    US FDA Launches Fast-Track Review Scheme for Generic Drugs

    AI Based Drug Discovery

    Bristol Myers, Takeda, Astex to Back AI Based Drug Discovery

    wearable drug delivery devices

    Wearable Drug Delivery Devices for On-Demand Care

    biologic drug formulation stability

    Breakthroughs in Biologic Drug Formulation Stability

    high volume injectable formulations

    Overcoming Challenges in High-Volume Injectable Formulations

    lipid nanoparticles in RNA therapies

    Lipid Nanoparticles in RNA and Gene Therapies

    Breast Cancer Therapy

    US FDA Approves Breast Cancer Therapy Inluriyo by Eli Lilly

  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us
No Result
View All Result
Pharma Advancement
No Result
View All Result
Home Health & Nutrition

Komodo Health Collaborates With Robert Wood Johnson Foundation To Advance New Research on Diet and Health

Content Team by Content Team
13th January 2024
in Health & Nutrition, Press Statements
Komodo Health Collaborates With Robert Wood Johnson Foundation To Advance New Research on Diet and Health

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Komodo Health, in collaboration with the Robert Wood Johnson Foundation (RWJF) and Mathematica, today announces a new program that will fund innovative studies to explore the impact of diet-related diseases across the country. As part of this news, the Diet-Related Health (DRH) Research Program is launching a competitive call for proposals, seeking new research projects focused on the impact of diet on health to accelerate new strategies for improving nutrition, preventing childhood obesity, and advancing diet-related health equity in the U.S.

The DRH program will award eight grantees free access to real-world data derived from Komodo’s Healthcare Map, which captures the comprehensive medical, clinical, laboratory, and pharmaceutical encounters of more than 330 million patients. Eligible research projects will focus on topics that facilitate a deeper understanding of the prevalence of diet-related diagnoses such as obesity, diabetes, and cardiovascular disease, as well as treatment for diet-related conditions and barriers to nutrition equity.

“We look forward to seeing how some of our country’s most creative and visionary researchers will leverage Komodo’s real-world data to evolve our collective understanding of diet-related health and disease,” said Katherine Hempstead, Senior Policy Adviser, RWJF.

Komodo Health, RWJF, and Mathematica will host an informational webinar on January 22 at 1 p.m. ET for interested applicants. It will include an overview of the de-identified real-world data that will be available to grantees for analysis within Komodo’s Healthcare Map. The Healthcare Map is accessed exclusively through Komodo’s technology platform and is the industry’s most complete source for assessing disease incidence, understanding patterns and disparities in patient care, and identifying U.S. healthcare system trends and prescribing patterns.

“The Robert Wood Johnson Foundation’s mission to build a Culture of Health drives crucial conversations on some of the most complex health and policy issues facing our nation today, and we are thrilled to contribute to their work by opening up the Healthcare Map for real-world evidence research,” said Web Sun, President and Co-Founder, Komodo Health. “It’s always been Komodo’s goal to reduce the burden of disease, and we are proud to offer grantees a stronger evidence base that can better quantify the effects of diet on health.”

Recipients of the DRH Research Grant are encouraged to submit scientifically rigorous, solution-oriented proposals from investigators representing diverse and/or historically underrepresented disciplines and backgrounds. All applicants must be based in the U.S. or its territories.

Previous Post

Rheonix Inc Publishes Cyclospora cayetanensis Data in Collaboration With FDA Center for Food Safety and Applied Nutrition

Next Post

Danone partners with digital oncology company Resilience for better nutritional care for patients with cancer

Related Posts

Packaging & Logistic

VarioFill: Rotzinger sets new standards with highly flexible filling and capping platform for OTC products

30th August 2025
Major Depressive Disorder
Americas

AbbVie to Acquire Gilgamesh Pharmaceuticals’ Bretisilocin, a Novel, Investigational Therapy for Major Depressive Disorder, Expanding Psychiatry Pipeline

27th August 2025
Schott-Testing
Press Statements

Carbon Reduced Pharmaceutical Glass: SCHOTT Melting Tank Construction Starts and External Certification for FIOLAX® Pro OCF

11th August 2025
GSK and Hengrui Pharma
Drug Development

GSK and Hengrui Pharma enter agreements to develop up to 12 innovative medicines across Respiratory, Immunology & Inflammation and Oncology

29th July 2025
Aptar Pharma Bolsters Clinical Trial.
Clinical Trials

Aptar Pharma Bolsters Clinical Trial Capabilities with Strategic Materials Manufacturing Acquisition

24th July 2025
Pharma Advancement Banner
Press Statements

Welcome to the Inaugural Operationalize: Expanded Access Programs Summit West

27th June 2025
Next Post
Danone partners with digital oncology company Resilience for better nutritional care for patients with cancer

Danone partners with digital oncology company Resilience for better nutritional care for patients with cancer

Qucik Links

  • Drug Development
  • Manufacturing
  • News
  • Events & Conferences
  • Newsletter Archive
Pharma Advancement

About Us

Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.

Subscribe Us

System

  • Search
  • Sitemap
  • RSS Feed

Resources

  • Advertise with us
  • Contact Us
  • Download Mediapack
  • Newsletters Archive

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

No Result
View All Result
  • Home
  • Articles
  • Drug Development
  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

Login to your account below

Forgotten Password?

Fill the forms bellow to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In